These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4221891)

  • 21. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
    Zembala M; Ptak W; Hanczakowska M
    Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The distribution of intraperitoneally injected colloidal particles in animals bearing implanted tumors of the mediastinum.
    Adlersberg L; Singer JM; Edberg SC
    J Reticuloendothel Soc; 1973 Dec; 14(6):571-86. PubMed ID: 4775530
    [No Abstract]   [Full Text] [Related]  

  • 23. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of extracts from Brazilian sun-mushroom (Agaricus blazei) on the NK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearing mice.
    Kaneno R; Fontanari LM; Santos SA; Di Stasi LC; Rodrigues Filho E; Eira AF
    Food Chem Toxicol; 2004 Jun; 42(6):909-16. PubMed ID: 15110099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody formation for malignant tumor. I. Antitumor activity of the regional lymph node protein.
    Yamamoto Y; Nakashima Y; Okano Y
    Gan; 1968 Apr; 59(2):109-16. PubMed ID: 5723055
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytological responses in tumor-bearing mice to phosphomucolipid.
    Mita A; Nakazawa M
    Gan; 1971 Dec; 62(6):459-70. PubMed ID: 5140491
    [No Abstract]   [Full Text] [Related]  

  • 27. [Data concerning protective substances in immune tissues (short report)].
    Glezer IM; Geĭtman IIa
    Biull Eksp Biol Med; 1968; 66(7):92-3. PubMed ID: 5758105
    [No Abstract]   [Full Text] [Related]  

  • 28. Study on the immunological reactivity of mice with solid Ehrlich adenocarcinoma.
    Botev B; Marholev L
    C R Acad Bulg Sci; 1970; 23(4):451-3. PubMed ID: 4919477
    [No Abstract]   [Full Text] [Related]  

  • 29. [The immunologic reactivity of mice with the ascitic form of Ehrlich carcinoma].
    Botev B; Markholev L
    Biull Eksp Biol Med; 1969 Dec; 68(12):70-1. PubMed ID: 5382331
    [No Abstract]   [Full Text] [Related]  

  • 30. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
    Okubo S
    Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
    [No Abstract]   [Full Text] [Related]  

  • 31. Demonstration of a reaction between immunocytes and tumor cells.
    Wrba H; Reider C
    Boll Ist Sieroter Milan; 1971; 50(4):329-33. PubMed ID: 5170764
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent splenocytes.
    Dobaczewska H
    Neoplasma; 1984; 31(2):165-8. PubMed ID: 6717686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor inhibition by means of sensitized regional lymph nodes.
    Arlen M; Forte RA; Levowitz BS; Scherrer J; Hodenberg M
    Surg Forum; 1969; 20():114-5. PubMed ID: 5383023
    [No Abstract]   [Full Text] [Related]  

  • 34. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
    Jakóbisiak M; Kańtoch M; Lasek W; Rozmysłowicz T; Obłakowski P; Dobaczewska H
    Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation.
    Tanino T
    Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction between subcutaneous and intraperitoneal transplants of the Ehrlich carcinoma; the possible role of anti-tumour antibody.
    Hallerbaker B; Hartveit F
    J Pathol; 1971 Oct; 105(2):95-103. PubMed ID: 5135342
    [No Abstract]   [Full Text] [Related]  

  • 37. Polysaccharide fraction of Agaricus brasiliensis avoids tumor-induced IL-10 production and changes the microenvironment of subcutaneous Ehrlich adenocarcinoma.
    Pinto AV; Martins PR; Romagnoli GG; Campanelli AP; Terezan AP; Filho ER; Ferreira da Eira A; Kaneno R
    Cell Immunol; 2009; 256(1-2):27-38. PubMed ID: 19243740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
    Masuda E; Maeda H
    Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of antitumor vaccine on the recurrence of solid tumors in mice subjected to surgery].
    Zatula DG; Bikhunov VL; Zagoruĭko EE
    Eksp Onkol; 1984; 6(1):47-9. PubMed ID: 6499731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Ehrlich ascites carcinoma on repopulating ability of mouse bone marrow cells.
    Clerici E; Mocarelli P; Villa ML; Natale N
    J Natl Cancer Inst; 1971 Sep; 47(3):555-60. PubMed ID: 4945589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.